Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Connie W Batlevi, MD,PhD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centre Hospitalier de Perpignan
Perpignan, Pyrénées-Orientales, France
- Hospital Universitario de Donostia
Donostia / San Sebastian, Guipúzcoa, Spain
- Hospital Universitario Vall D'Hebrón
Barcelona, Spain
- Hospital del Mar
Barcelona, Spain
- C.H. Regional Reina Sofia
Córdoba, Spain
- Hospital Universitario Infanta Leonor
Madrid, Spain
- Advocate Medical Group - Park Ridge, Luther Lane - Oncology
Park Ridge, Illinois, United States
- Norton Cancer Institute - St. Matthews Campus
Louisville, Kentucky, United States
- Clinical Research Alliance Inc
Lake Success, New York, United States
- Manhattan Hematology Oncology Center
New York, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Bone Marrow Transplant Hematology Oncology Associates
Pittsburgh, Pennsylvania, United States
- Arlington Cancer Center
Arlington, Texas, United States
- Central Texas Veterans Health Care System - Navref
Temple, Texas, United States
- Vista Oncology Inc. Ps
Olympia, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Aug 2018
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2029
- Last update posted
- 10 Apr 2025
- Registered enrollment
- 139
- Registry id
- NCT03600441
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.